Brief: IN8bio Reports Q4 And Full-Year 2021 Financial Results
March 17 (Reuters) - IN8BIO, Inc. INAB.O :
* IN8BIO REPORTS FOURTH QUARTER AND FULL-YEAR 2021 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.44
* AS OF DECEMBER 31, 2021, COMPANY HAD CASH OF $37.0 MILLION
* NET LOSS OF $5.9 MILLION, OR $0.44 PER BASIC AND DILUTED
COMMON
SHARE, FOR THREE MONTHS ENDED DECEMBER 31, 2021
Source text for Eikon: ID:nGNXT0y22
Further company coverage: INAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall